RedHill Biopharma Ltd. Gains 21.94%
Thu, Oct 08, 2026 at 07:39 PM
RedHill Biopharma Ltd. (RDHL:NASDAQ) jumped higher at $0.58, a gain of 21.9%. On Thu, Oct 08, 2026, RDHL:NASDAQ touched a New 2-Week High of $0.58. The stock got featured on our News Catalysts scanner on Fri, Oct 02, 2026 at 02:50 AM in the 'PATENT' category. From Thu, Sep 24, 2026, the stock recorded 20.00% Up Days and 18.18% Green Days
The stock spiked on Mon, Aug 31, 2026 at $1.6 with a volume of 104M+.
About RedHill Biopharma Ltd. (RDHL:NASDAQ)
RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.
Top 10 Gainers:
- Fly-E Group, Inc. (FLYE:NASDAQ), 82.68%
- Jianzhi Education Technology Group Company Limited (JZ:NASDAQ), 77.44%
- Xiao-I Corporation (AIXI:NASDAQ), 46.21%
- Pacira BioSciences, Inc. (PCRX:NASDAQ), 44.4%
- Quanome Technologies Inc Com (QNME:NASDAQ), 43.28%
- The OLB Group, Inc. (OLB:NASDAQ), 41.86%
- WISeSat.Space Holdings Corp. (SAIQ:NASDAQ), 41.65%
- Grande Group Limited (GRAN:NASDAQ), 23.12%
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 21.94%
- Profound Medical Corp. (PROF:NASDAQ), 21.65%